This study explored the relationships between expression of VEGFR-2, PDGFR-β, and c-Met and the clinicopathological factors and prognosis of HCC patients, aiming to provide reference information to assist with the diagnosis, evaluation of prognosis, and targeted therapy of HCC. The gene discussed is MET; the disease is hepatocellular carcinoma.